Holding types
Countries
Sectors
No data
Analyst ratings
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Top Performing Leveraged/Inverse ETFs: 11/17/2024
BIS
etftrends.com19 November 2024
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
LBMA and WGC met with BIS to reclassify gold as a High-Quality Liquid Asset under new Basel III banking rules: GJEPC report
BIS
kitco.com11 July 2024
Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
Best Inverse/Leveraged ETFs of Last Week
BIS
Zacks Investment Research26 June 2023
Wall Street gave a muted performance last week as the S&P 500 and the Nasdaq snapped the prolonged winning streak.
FAQ
- What is BIS ETF?
- Does BIS pay dividends?
- What stocks are in BIS ETF?
- What is the current assets under management for BIS?
- What is BIS average volume?
- What is BIS expense ratio?
- What is BIS inception date?
What is BIS ETF?
The BIS ETF (Bank for International Settlements Exchange-Traded Fund) is an investment fund that tracks the performance of a specific index or asset class. It allows investors to buy shares that represent a diversified portfolio, providing exposure to various financial markets with lower costs and increased liquidity.
Does BIS pay dividends?
Yes, the ProShares UltraShort Nasdaq Biotechnology does pays dividends, with
the most recent payment being
$0.15
per share. The last ex-dividend date was on 25 September 2024, and the next ex-dividend date has not been announced yet
What stocks are in BIS ETF?
As of today, ProShares UltraShort Nasdaq Biotechnology inlcudes 8 holdings
with the most weighted are NASDAQ Biotechnology Index SWAP Societe Generale (25.51%), NASDAQ Biotechnology Index SWAP UBS AG (22.24%) and Net Other Assets (Liabilities) (19.28%)
What is the current assets under management for BIS?
Assets under management of ProShares UltraShort Nasdaq Biotechnology is $4 M
What is BIS average volume?
Average volume of ProShares UltraShort Nasdaq Biotechnology is $15 K
What is BIS expense ratio?
Expense ratio of ProShares UltraShort Nasdaq Biotechnology is 0.95%
What is BIS inception date?
Inception date of ProShares UltraShort Nasdaq Biotechnology is 09 April 2010